Agios Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 63 U.S.-traded ETFs. AGIO has around 8.2M shares in the U.S. ETF market. The largest ETF holder of AGIO is the SPDR S&P Biotech ETF (XBI), with approximately 1.77M shares. Investors may also find of interest that the ETF with the largest allocation to AGIO stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 2.50%. On average, U.S. ETFs allocate 0.22% of AGIO to their portfolios.
Additionally, AGIO is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AGIO as a holding is the ProShares Ultra Health Care (RXL), with a return of 28.34%.